-
March 30, 2012
The top White House official for intellectual property Friday sent Capitol Hill a 130-page report documenting enforcement efforts, but declined to endorse further legislative efforts to target online piracy
-
March 30, 2012
Panellists at Managing IP’s inaugural US Patent Reform Forum this week debated whether the estoppel language tied to post grant review proceedings under the America Invents Act warrants a technical correction by Congress
-
March 30, 2012
Have you been paying attention to the week’s news? Test your knowledge with Managing IP’s five questions
-
March 29, 2012
Quinn Emanuel Urquhart & Sullivan received three awards at the fifth annual North America Awards in Washington DC, in recognition of the firm’s active role in the so-called smartphone wars at the ITC and in the courts
-
March 29, 2012
Leading firms from the US and Canada were honoured at Managing IP's fifth annual awards ceremony this week
-
March 29, 2012
US Senator Patrick Leahy and Congressman Lamar Smith this week received outstanding achievement awards for their part in passing the America Invents Act
-
March 29, 2012
Chinese consumers will soon find the words “patent pending” on their products after new measures to crack down on the false patent marking
-
March 29, 2012
Becton Dickinson has prevailed against Therasense under the heightened inequitable conduct standard – defying the notion that the doctrine had been rendered obsolete by the Federal Circuit
-
March 28, 2012
The Public Patent Foundation has filed a notice of appeal in the Federal Circuit in a false marking case regarding Tylenol products
-
March 27, 2012
IP owners who sue infringers under the UK’s new small claims track cannot request interim injunctions or be awarded more than £5,000 in damages
-
March 26, 2012
The US Supreme Court today granted cert in Association for Molecular Pathology v Myriad Genetics, vacating the judgment and remanding the case to the Federal Circuit
-
March 26, 2012
The number of patents granted in the UK last year rose by more than a third, the largest leap in a decade
-
March 26, 2012
“Licensing is the path forward”, Microsoft's corporate vice president and deputy general counsel of IP tells Eileen McDermott, explaining why it has shunned the patent wars
-
March 26, 2012
Patent filings at the EPO reached a record level last year, with applications from Asian companies making up a bigger share of the total than ever
-
March 23, 2012
Brazil may soon have guidelines on software patents, which will be almost identical to those in Europe
-
March 23, 2012
Managing IP’s second International Patent Forum will feature keynote speeches from EPO President Benoît Battistelli, USPTO Director David Kappos and WIPO Deputy Director-General Jim Pooley
-
March 23, 2012
How many questions on the week’s IP news can you answer?
-
March 21, 2012
The shortlist for the inaugural Euromoney Legal Media Group Americas Women in Business Law Awards has been announced
-
March 21, 2012
The Ministry of Law has proposed an amendment to the Patents Act that will allow foreign-registered patent agents to conduct offshore work in Singapore
-
March 20, 2012
While there could be trouble ahead for diagnostic method patents following the Supreme Court ruling in Mayo v Prometheus, lawyers cautioned against viewing the decision as a death knell
-
March 20, 2012
In the most important ruling on patentable subject matter since Bilski v Kappos, Mayo has successfully convinced the highest US court that the diagnostic method patents owned by Prometheus are invalid
-
March 19, 2012
The High Court in London has granted an interim injunction against Teva to stop it launching a generic version of efavirenz, even though Teva had done nothing more than get market authorisation
-
March 19, 2012
A senior figure within India’s generic drugs industry says that more domestic companies are waiting to file applications for compulsory licences over patented pharmaceuticals
-
March 16, 2012
Managing IP lists some of the decisions, meetings and events IP professionals should watch out for next week
-
March 16, 2012
Test your knowledge of IP news with our five quick questions on the past week’s developments
-
March 16, 2012
The Marks & Clerk group has launched two new IP consultancy businesses in London and Paris
-
March 15, 2012
Hogan Lovells won the inaugural global IP firm of the year award at tonight’s Managing IP Awards Dinner in London
-
March 15, 2012
Leading IP firms from around the world were recognised at Managing IP’s Global Awards 2012 in London tonight
-
March 15, 2012
A divided 10-judge panel of the Federal Circuit today handed down a decision that could have major implications for strategies tied to the new post-grant procedures mandated by the America Invents Act
-
March 15, 2012
Korea’s legal market is opening up to US firms, with eight so far planning to practise there. How will IP work be affected?
-
March 14, 2012
Quinn Emanuel is becoming something of an authority on the art of patent fighting
-
March 13, 2012
Yahoo!’s patent lawsuit against Facebook may signal it is joining the ranks of companies such as Kodak in attempting to monetise key technology to keep revenue flowing
-
March 13, 2012
The UK Parliament’s All-Party Intellectual Property Group has launched an inquiry into the role of government in protecting and promoting intellectual property
-
March 12, 2012
Today India has granted its first compulsory licence over a drug. But what of other countries that have used the IP system to make it easier for patients to access medicines?
-
March 12, 2012
In one of his final tasks before leaving the job, the outgoing head of India’s patent office has issued the country’s first compulsory licence over a drug since India began protecting pharmaceutical products seven years ago
-
March 12, 2012
India’s Controller of Patents has issued a compulsory licence over a cancer-treating drug, sorafenib, whose patent is held by Bayer
-
March 09, 2012
Managing IP lists IP events and meetings scheduled for the week beginning March 12
-
March 09, 2012
Each Friday, Managing IP tests your knowledge of the week’s IP news with five questions on the week’s news. How many can you answer?
-
March 09, 2012
Patent owners in India that want to enforce their rights in the courts have to deal with a series of obstacles. Pharmaceutical patents involve extra hurdles
-
March 09, 2012
Patent practitioners revealed a series of issues with India’s complex prosecution system at Managing IP’s India IP and Innovation Forum last week
-
March 08, 2012
The US law on patentable subject matter has become muddied in a “swamp of verbiage”, according to the Federal Circuit in its ruling in MySpace v GraphOn
-
March 08, 2012
The majority’s opinion in MySpace v GraphOn singled out the controversial topic of differing approaches to claim construction - an area of law that, like patent eligibility, many feel has become unpredictable in recent years
-
March 06, 2012
As the US Republican presidential candidates await the results of Super Tuesday, they are also being sued in California for patent infringement
-
March 05, 2012
Joe Biden said the Chinese can’t innovate. But new figures show that PCT applications from China grew by a third last year – and for the first time a Chinese company is ranked number one for published patents
-
March 02, 2012
Acting deputy secretary of commerce Rebecca Blank has sworn in nine new administrative patent judges to the USPTO’s Board of Patent Appeals and Interferences
-
March 02, 2012
Managing IP lists IP events and meetings scheduled for the week beginning March 5
-
March 02, 2012
Test your knowledge of the week’s IP news with our weekly quiz – all answers available on managingip.com
-
March 02, 2012
Dave Kappos and Robert Armitage will headline Managing IP’s unique forum on US patent reform in Washington DC this month
-
March 02, 2012
Brussels was the setting for impassioned debate over the EU's approach to ACTA this week. But it wasn’t the only place where concerns were raised in Europe
-
March 02, 2012
Two new firms debut in this year’s Latin America trade mark rankings and another makes the leap into tier 1
-
March 01, 2012
As patent owners in the personalised medicine sector wait to see if the Supreme Court will hear the Myriad gene patent case, other industries are bracing themselves for unintended consequences
-
March 01, 2012
The Supreme Court was set to decide whether to grant the Association for Molecular Pathology’s petition to hear its gene patent case against Myriad last Monday, but Mayo v Prometheus could be holding things up